Summaries for patients. Preventing bone loss in men with prostate cancer
- PMID: 17371883
- DOI: 10.7326/0003-4819-146-6-200703200-00001
Summaries for patients. Preventing bone loss in men with prostate cancer
Original report in
-
Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.Ann Intern Med. 2007 Mar 20;146(6):416-24. doi: 10.7326/0003-4819-146-6-200703200-00006. Ann Intern Med. 2007. PMID: 17371886 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical